Search results
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via AOL· 4 hours agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...
Astrazeneca: Q1 Earnings Snapshot
Houston Chronicle· 53 minutes agoCAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday...
Trending tickers: Microsoft, Google, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's
Yahoo Finance UK· 6 minutes ago“We saw both a lengthening of backlog duration driven by large scale digital transformations and a...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 4 hours agoAstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu.
AstraZeneca Earnings, Sales Rise, Beat Forecasts
The Wall Street Journal· 2 hours agoHEALTH AstraZeneca posted increased first-quarter core earnings per share and sales that beat forecasts. The Anglo-Swedish pharmaceutical giant said...
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer...
Fortune· 26 minutes agoEarnings per share excluding some items rose 7% to $2.06 in the first quarter, the UK drugmaker said Thursday. Analysts surveyed by Bloomberg expected $1.89 on average. Astra has been on a deal ...
AstraZeneca drops GOLDILOX and the porcupine in R&D update
FierceBiotech· 3 hours agoAstraZeneca’s first-quarter results (PDF) put a twist on a fairy tale, telling the lesser-known...
AstraZeneca beats revenue, profit estimates on resilient demand
Reuters· 4 hours agoAstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by...
FTSE 100 Live: Index at record; Anglo American soars on BHP bid; Barclays, AstraZeneca up
Proactive Investors· 3 hours agoWH Smith PLC (LSE:SMWH) fell 7.8% on Thursday morning after unveiling a fall in interim operating...
Deutsche Bank Aktiengesellschaft Reiterates “Hold” Rating for AstraZeneca (LON:AZN)
ETF DAILY NEWS· 7 hours agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Tuesday ...